Cargando…
A clinical study of genetic testing to guide the dosing of warfarin after heart valve replacement
OBJECTIVE: To explore the role of genetic testing of VKORC1 and CYP2C9 in determining the dosage of warfarin after aortic valve replacement. METHODS: A total of 172 patients receiving warfarin after aortic valve replacement were divided into a control group (n = 86) and an experimental (n = 86) grou...
Autores principales: | Zhang, Fan, Zhang, Congcong, Gu, Chengxiong, Yu, Yang, Li, Jingxing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019963/ https://www.ncbi.nlm.nih.gov/pubmed/35439929 http://dx.doi.org/10.1186/s12872-022-02620-x |
Ejemplares similares
-
Clinical and genetic factors associated with warfarin maintenance dose in northern Chinese patients with mechanical heart valve replacement
por: Liu, Rui, et al.
Publicado: (2017) -
Verification of Pharmacogenetics-Based Warfarin Dosing Algorithms in Han-Chinese Patients Undertaking Mechanic Heart Valve Replacement
por: Zhao, Li, et al.
Publicado: (2014) -
Genotype-guided warfarin dosing may benefit patients with mechanical aortic valve replacements: randomized controlled study
por: Lee, Kyung Eun, et al.
Publicado: (2020) -
Warfarin maintenance dose Prediction for Patients undergoing heart valve replacement— a hybrid model with genetic algorithm and Back-Propagation neural network
por: Li, Qian, et al.
Publicado: (2018) -
Warfarin maintenance dose prediction for Chinese after heart valve replacement by a feedforward neural network with equal stratified sampling
por: Ma, Weijie, et al.
Publicado: (2021)